高福院士:希望明年初基本达成群体免疫,即约9至10亿人接种疫苗

2021-03-22 网络 网络

中国疾病预防控制中心主任高福日前在接受央视采访时表示,希望到2022年年初、甚至今年年底,中国能达到70%-80%的新冠疫苗接种率(即大约9亿至10亿人口已经接种),基本实现群体免疫。

中国疾病预防控制中心主任高福日前在接受央视采访时表示,希望到2022年年初、甚至今年年底,中国能达到70%-80%的新冠疫苗接种率(即大约9亿至10亿人口已经接种),基本实现群体免疫

高福说:“疫苗的接种是一个相当复杂的综合过程,大家都在努力,我希望说‘明年年初’是说错了,希望今年年底我们就能实现,本身这句话也是希望推进、加快这个过程。”

中国疾病控制预防中心主任高福表示,疫苗是战胜病毒的终极武器。疫苗和病毒关系非常清晰,有效的疫苗就能够把传染病消灭、消除或者控制。

高福直言,新冠病毒走到今天,没有证据表明它将消失,很可能将会和人类共存,就像流感一样,而且还会出现新的冠状病毒。“人类和病毒的关系就是猫鼠关系。”

高福还谈了西安检验师打疫苗仍感染的情况,主要是有三种可能情况:

1、打了疫苗以后体内产生抗体,但病毒感染在呼吸道,体内抗体可能对防止呼吸道感染不那么好;

2、少数人属于新冠疫苗接种不反应者,由于新冠疫苗刚刚开始接种,不反应人群的占比还没有统计出;

3、打了两针灭活疫苗,抗体滴度不够,可能需要补第三针。

高福指出,不能因个案否定全盘,要抓紧对个案进行研究。疫苗保护的是群体,个案出现的科学问题,要用科学的态度去解决。同时他认为,该个案暂时不会对整个的疫情防控方案有多大影响。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1717064, encodeId=314e1e17064fa, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Tue Nov 16 14:01:34 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632377, encodeId=276f16323e7c1, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Sat Feb 05 15:01:34 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049279, encodeId=221a10492e987, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Mar 22 13:01:34 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950070, encodeId=3f909500e0f6, content=一人生病,全国吃药,院士的选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=434, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Mar 22 10:26:41 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950063, encodeId=0ffe950063b6, content=加油加油高院士, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d525399094, createdName=plumchou, createdTime=Mon Mar 22 10:10:58 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-11-16 xjy13
  2. [GetPortalCommentsPageByObjectIdResponse(id=1717064, encodeId=314e1e17064fa, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Tue Nov 16 14:01:34 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632377, encodeId=276f16323e7c1, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Sat Feb 05 15:01:34 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049279, encodeId=221a10492e987, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Mar 22 13:01:34 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950070, encodeId=3f909500e0f6, content=一人生病,全国吃药,院士的选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=434, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Mar 22 10:26:41 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950063, encodeId=0ffe950063b6, content=加油加油高院士, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d525399094, createdName=plumchou, createdTime=Mon Mar 22 10:10:58 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1717064, encodeId=314e1e17064fa, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Tue Nov 16 14:01:34 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632377, encodeId=276f16323e7c1, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Sat Feb 05 15:01:34 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049279, encodeId=221a10492e987, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Mar 22 13:01:34 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950070, encodeId=3f909500e0f6, content=一人生病,全国吃药,院士的选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=434, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Mar 22 10:26:41 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950063, encodeId=0ffe950063b6, content=加油加油高院士, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d525399094, createdName=plumchou, createdTime=Mon Mar 22 10:10:58 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-03-22 junJUN

    院士是学术至高点,也是大家必争之地呀

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1717064, encodeId=314e1e17064fa, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Tue Nov 16 14:01:34 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632377, encodeId=276f16323e7c1, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Sat Feb 05 15:01:34 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049279, encodeId=221a10492e987, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Mar 22 13:01:34 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950070, encodeId=3f909500e0f6, content=一人生病,全国吃药,院士的选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=434, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Mar 22 10:26:41 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950063, encodeId=0ffe950063b6, content=加油加油高院士, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d525399094, createdName=plumchou, createdTime=Mon Mar 22 10:10:58 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-03-22 wwjxx

    一人生病,全国吃药,院士的选择

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1717064, encodeId=314e1e17064fa, content=<a href='/topic/show?id=f8a98002eb1' target=_blank style='color:#2F92EE;'>#群体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80027, encryptionId=f8a98002eb1, topicName=群体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c0832353243, createdName=xjy13, createdTime=Tue Nov 16 14:01:34 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632377, encodeId=276f16323e7c1, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Sat Feb 05 15:01:34 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049279, encodeId=221a10492e987, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Mar 22 13:01:34 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950070, encodeId=3f909500e0f6, content=一人生病,全国吃药,院士的选择, beContent=null, objectType=article, channel=null, level=null, likeNumber=434, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Mar 22 10:26:41 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950063, encodeId=0ffe950063b6, content=加油加油高院士, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d525399094, createdName=plumchou, createdTime=Mon Mar 22 10:10:58 CST 2021, time=2021-03-22, status=1, ipAttribution=)]
    2021-03-22 plumchou

    加油加油高院士

    0

相关资讯

高福委员呼吁:消除狂犬病,把疫苗打给狗

2月25日,“两会”到来之前一个普通的周一。国家卫生健康委员会召开例行发布会,邀请“两会”代表委员谈健康。据不完全统计,在我国卫生健康系统领域里有200多名“两会”代表委员。全国政协委员、中国科学院院士、中国疾控中心主任高福便是其中的一员。在发布会的提问过程中,记者将绝大部分问题抛给了他,发布结束时,他更是被一百多家媒体团团围住。

Science:热点:《科学》杂志专访高福院士:不戴口罩预防冠状病毒是一个“大错误”

近日,《科学》杂志通过短信、语音邮件和电话交谈采访了中国疾病预防控制中心(CDC)主任高福院士,为简洁明了起见,对本采访进行了编辑。

高福院士团队新冠病毒重组蛋白亚单位疫苗启动Ⅲ期临床试验

11月18日,中国科学院微生物研究所高福院士团队与重庆智飞生物制品股份有限公司(智飞生物)联合研制的新冠病毒重组蛋白亚单位疫苗,在湖南省湘潭市湘潭县开始国内部分的III期临床试验。

Cell Rep:H4亚型禽流感病毒研究获进展

国科学院院士、中科院北京生命科学研究院副院长高福团队在H4亚型禽流感病毒适应人的分子机制和跨种间传播预警预测方面取得新的重要进展。研究结果以《H4亚型流感病毒血凝素蛋白从结合禽源到人源受体适应的分子基础》为题,于8月1日在线发表在国际学术期刊Cell Reports上

高福院士:艾滋病疫苗突破需要颠覆性思维

艾滋病正在逐渐变为一种可控的慢性疾病,但预防艾滋病的有效疫苗还未被人类开发出来。问及如何看待艾滋病疫苗的前景和发展方向时,中国疾病预防控制中心副主任、中国科学院院士高福表示:“艾滋病疫苗可能会解决,但是解决的方法一定不是现有的技术,需要完全是颠覆性的才可能解决。”

高福谈新冠疫苗研发:灭活疫苗中国走得很快 反馈的效果也很好

近日,多款新冠疫苗陆续获批并开始在多国大规模接种。中国攻坚克难,以严谨规范态度进行疫苗研发……目前全球疫苗有哪些不同类型?中国的疫苗研发经历了怎样的过程?科学家对新冠肺炎病